Anika Therapeutics, Inc. Number of Reporting Units
Anika Therapeutics, Inc. (ANIK) reported Number of Reporting Units of 200.00% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-03.
Financial Statements › Notes
us-gaap:NumberOfReportingUnits · last filed 2026-03-03
- Anika Therapeutics, Inc. number of reporting units for the quarter ending 2020-03-31 was 200.00%.
- Anika Therapeutics, Inc. number of reporting units for fiscal 2025 was 200.00%, a 0.00% change from fiscal 2024.
- Anika Therapeutics, Inc. number of reporting units for fiscal 2024 was 200.00%, a 0.00% change from fiscal 2023.
- Anika Therapeutics, Inc. number of reporting units for fiscal 2023 was 200.00%, a 0.00% change from fiscal 2022.
- Anika Therapeutics, Inc. number of reporting units for fiscal 2022 was 200.00%, a 0.00% change from fiscal 2021.
| Period end | Number of Reporting Units 3 month | Number of Reporting Units 6 month | Number of Reporting Units 9 month | Number of Reporting Units 12 month |
|---|---|---|---|---|
| 2025-12-31 | 200.00% 10-K · filed 2026-03-03 | |||
| 2024-12-31 | 200.00% 10-K · filed 2025-03-17 | |||
| 2023-12-31 | 200.00% 10-K · filed 2024-03-15 | |||
| 2022-12-31 | 200.00% 10-K · filed 2023-03-16 | |||
| 2021-12-31 | 200.00% 10-K · filed 2022-03-11 | |||
| 2020-12-31 | 200.00% 10-Q · filed 2021-05-07 | |||
| 2020-09-30 | 200.00% 10-Q · filed 2020-11-05 | |||
| 2020-06-30 | 200.00% 10-Q · filed 2020-08-07 | |||
| 2020-03-31 | 200.00% 10-Q · filed 2020-05-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |